Accelerate Diagnostics
About
Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $45M
- Industries
- Consulting,Health Care,Health Diagnostics,Hospital,Information Technology
- Founded date
- Jan 1, 2004
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity.It was founded in 2004 and is headquartered in Tucson, Arizona.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 5, 2014 | Post-IPO Equity | $45M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Oracle
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
